Diabetic Ketoacidosis Associated with Sodium-Glucose Cotransporter 2 Inhibitors: Clinical and Biochemical Characteristics of 29 Cases

OBJECTIVE: To describe the clinical and biochemical characteristics of all reported cases of DKA associated with SGLT2 inhibitor use in patients with type 2 diabetes mellitus and to identify potential risk factors. DESIGN: A retrospective case series was conducted between March 2013 and August 2019...

Descripción completa

Detalles Bibliográficos
Autores principales: Stamatiades, G. A., D'Silva, P., Elahee, M., Viana, G. M., Sideri-Gugger, A., Majumdar, S. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335870/
https://www.ncbi.nlm.nih.gov/pubmed/37441367
http://dx.doi.org/10.1155/2023/6615624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335870/
https://www.ncbi.nlm.nih.gov/pubmed/37441367
http://dx.doi.org/10.1155/2023/6615624

Ejemplares similares